Biodisposition and metabolism of [18F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 6, 2008, Pages 1192-1203

  Bansal, Aditya ^a   Shuyan, Wang ^a   Hara, Toshiko ^a   Harris, Robert A ^a   DeGrado, Timothy R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

9L glioma; 18F; Choline; Fluorocholine; Hypoxia; Metabolism; Rat

Indexed keywords

BETAINE; BETAINE C 14; CARBON 14; CHOLINE C 14; FLUORINE 18; FLUOROBETAINE F 18; FLUOROCHOLINE F 18;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG METABOLISM; DRUG STRUCTURE; GLIOMA; GLIOMA CELL; HYPOXIA; MALE; NONHUMAN; RAT;

ANIMALS; CELL LINE, TUMOR; CHOLINE; GLIOMA; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; RATS; RATS, INBRED F344; TISSUE DISTRIBUTION;

EID: 43749106842     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0736-y     Document Type: Article

References (33)

1. Gillies RJ, Morse DL. In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng. 2005;7:287-26.
2. DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD, Robertson CN, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2001;61(1):110-7.
3. Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res. 2002;62(7):1966-70.
4. Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells: NMR application of the zero trans method. Anticancer Res. 1996;16(3B):1375-80.
5. Hara T, Kosaka N, Kishi H. Development of 18F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med. 2002;43(2):187-99.
6. Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, Martinez-Pineiro L, Sanchez J, Bonilla F, et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun. 2002;296(3):580-3.
7. Shinoura N, Nishijima M, Hara T, Haisa T, Yamamoto H, Fujii K, et al. Brain tumors: detection with C-11 choline PET. Radiology. 1997;202(2):497-503.
8. Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med. 1997;38(6):842-7.
9. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998;39(6):990-5.
10. Hara M. Clinical studies on cefoperazone and polymyxin B for the treatment of infections in patients with hematological malignancies. Jpn J Antibiot. 1987;40(9):1639-43.
11. DeGrado TR, Baldwin SW, Wang S, Orr MD, Liao RP, Friedman HS, et al. Synthesis and evaluation of 18F-labeled choline analogs as oncologic PET tracers. J Nucl Med. 2001;42(12):1805-14.
12. Talbot JN, Gutman F, Fartoux L, Grange JD, Ganne N, Kerrou K, et al. PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CT. Eur J Nucl Med Mol Imaging 2006;33(11):1285-9. Jun 27.
13. Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med. 2006;47(2):262-9.
14. Heinisch M, Dirisamer A, Loidl W, Stoiber F, Gruy B, Haim S, et al. Positron emission tomography/computed tomography with F-18 fluorocholine for restaging of prostate cancer patients: meaningful at PSA<5 ng/ml? Mol Imaging Biol. 2006;8(1):43-8.
15. Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, et al. [18F] fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006;33(12):1387-98. July 25.
16. Schmid DT, John H, Zweifel R, Cservenyak T, Westera G, Goerres GW, et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology. 2005;235(2):623-8.
17. Kwee SA, Coel MN, Lim J, Ko JP. Prostate cancer localization with fluorine-18 fluorocholine positron emission tomography. J Urol. 2005;173(1):252-5.
18. Kwee SA, Coel MN, Lim J, Ko JP. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation. J Neuroimaging. 2004;14(3):285-9.
19. Price DT, Coleman RE, Liao RP, Robertson CN, Polascik TJ, DeGrado TR. Comparison of [18F]fluorocholine and [18F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol. 2002;168(1):273-80.
20. Roivainen A, Forsback S, Gronroos T, Lehikoinen P, Kahkonen M, Sutinen E, et al. Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography. Eur J Nucl Med. 2000;27(1):25-32.
21. Jenkins WT, Evans SM, Koch CJ. Hypoxia and necrosis in rat 9L glioma and morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode. Int J Radiation Oncology Biol Phys. 2000;46(4):1005-17.
22. Liu L, Cash TP, Jones RG, Keith B, Thompson CB, Simon MC. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell. 2006;21:521-31.
23. Lamprecht W, Trautschold I. Determination of ATP by hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. 2nd ed. New York: Academic; 1974. p. 2101-10.
24. Ishidate K, Nakazawa Y. Choline/ethanolamine kinase from rat kidney. Methods Enzymol. 1992;209:121-34.
25. Haubrich DR, Wang PF, Wedeking PW. Distribution and metabolism of intravenously administered choline[methyl- 3-H] and synthesis in vivo of acetylcholine in various tissues of guinea pigs. J Pharmacol Exp Ther. 1975;193(1):246-55.
26. Finkelstein JD, Martin JJ, Harris BJ, Kyle WE. Regulation of the betaine content of rat liver. Arch Biochem Biophys. 1982;218(1):169-73.
27. Garcia-Perez A, Burg MB. Role of organic osmolytes in adaptation of renal cells to high osmolality. J Membr Biol. 1991;119:1-13.
28. Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. Faseb J. 1994;8(12):957-67.
29. Pennington RJ, Worsfold M. Biosynthesis of lecithin by skeletal muscle. Biochim Biophys Acta. 1969;176(4):774-82.
30. Shamgar FA, Collins FD. Incorporation of ortho[32P]phosphate into phosphatidylcholines and phosphatidylethanolamines in rat skeletal muscle. Biochim Biophys Acta. 1975;409(1):104-15.
31. Hara T, Bansal A, DeGrado TR. Effect of hypoxia on uptake of [methyl-3H]choline, [1-14C]acetate and [18F]FDG in cultured prostate cancer cells. Nucl Med Biol. 2006;33(8):977-84. Nov.
32. Sarri E, Garcia-Dorado D, Abellan A, Soler-Soler J. Effects of hypoxia, glucose deprivation and acidosis on phosphatidylcholine synthesis in HL-1 cardiomyocytes. CTP: phosphocholine cytidylyltransferase activity correlates with sarcolemmal disruption. Biochem J. 2006;394(1):325-34. Feb 15.
33. Jacobs RL, Lingrell S, Dyck JR, Vance DE. Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-beta-4- ribofuranoside is independent of AMP-activated protein kinase activation. J Biol Chem. 2007;282(7):4516-23. Feb 16.